New discovery could reduce arsenic contamination in water

A study led by the University of Bristol shedding new light on how arsenic can be made less dangerous to humans has the potential to dramatically improve water and food safety, especially in the Global South.

Risk Adjusted Net Present Value: What is the current valuation of Sandoz Group’s Aflibercept Biosimilar

The revenue for Aflibercept Biosimilar is expected to reach an annual total of $146 mn by 2039 globally based off GlobalData’s Revenue Model. The drug’s

November 4, 2023

Pfizer and Valneva say second Lyme booster led to ‘strong’ responses, target 2026 FDA submission

Pfizer and Valneva said patients demonstrated “strong immune responses” after receiving a second booster dose of their experimental Lyme disease vaccine, supporting the case for

September 4, 2024

Androgen deprivation therapy increases the risk of depression, dementia, Alzheimer’s disease, and Parkinson’s disease

The association between Androgen Deprivation Therapy (ADT) and the risk of dementia.

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.